Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-05-17
2011-05-17
Ouspenski, Ilia (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
Reexamination Certificate
active
07943743
ABSTRACT:
The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies that specifically bind to PD-L1 with high affinity. Nucleic acid molecules encoding the antibodies of this disclosure, expression vectors, host cells and methods for expressing the antibodies of this disclosure are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of the invention are also provided. The disclosure also provides methods for detecting PD-L1, as well as methods for treating various diseases, including cancer and infectious diseases, using anti-PD-L1 antibodies.
REFERENCES:
patent: 6300064 (2001-10-01), Knappik et al.
patent: 6632927 (2003-10-01), Adair et al.
patent: 6803192 (2004-10-01), Chen
patent: 6808710 (2004-10-01), Wood et al.
patent: 6881557 (2005-04-01), Foote
patent: 6936704 (2005-08-01), Freeman et al.
patent: 6965018 (2005-11-01), Mikesell et al.
patent: 7029674 (2006-04-01), Carreno et al.
patent: 7038013 (2006-05-01), Freeman et al.
patent: 7041474 (2006-05-01), Kingsbury
patent: 7101550 (2006-09-01), Wood et al.
patent: 7279567 (2007-10-01), Mikesell et al.
patent: 7358354 (2008-04-01), Mikesell et al.
patent: 7368531 (2008-05-01), Rosen et al.
patent: 7368554 (2008-05-01), Mikesell et al.
patent: 7385036 (2008-06-01), Kingsbury
patent: 7396917 (2008-07-01), Bowdish et al.
patent: 7501496 (2009-03-01), Endl et al.
patent: 2002/0102651 (2002-08-01), Freeman et al.
patent: 2003/0031675 (2003-02-01), Mikesell et al.
patent: 2003/0039653 (2003-02-01), Chen et al.
patent: 2005/0059051 (2005-03-01), Chen
patent: 2006/0083744 (2006-04-01), Chen et al.
patent: 2006/0153841 (2006-07-01), Freeman et al.
patent: 2007/0092504 (2007-04-01), Carreno et al.
patent: 2007/0202100 (2007-08-01), Wood et al.
patent: 2008/0213778 (2008-09-01), Holtzman et al.
patent: 1 537 878 (2005-08-01), None
patent: WO 01/14556 (2001-03-01), None
patent: WO 01/14557 (2001-03-01), None
patent: WO 01/34768 (2001-05-01), None
patent: WO 01/39722 (2001-06-01), None
patent: WO 02/086083 (2002-10-01), None
patent: WO 2006/042237 (2006-04-01), None
Rudikoff et al. 1982, Proc. Natl. Acad. Sci. USA, , 79: 1979-1983.
Panka et al., 1988, Proc. Natl. Acad. Sci. USA, 85: 3080-3084.
Klimka et al. British J. of Cancer (2000);83(2):252-260.
Beiboer et al. J. Mol. Biol. (2000);296:833-849.
Rader et al. PNAS USA (1998);95:8910-8915.
Xu et al. (2000) Immunity, 13: 37-45.
Koga et al. “Blockade of the Interaction Between PD-1 and PD-L1 Accelerates Graft Arterial Disease in Cardiac Allografts”;Arterioscler. Thromb. Vasc. Biol.; (2004); 24(11):2057-2062.
Blank et al. “PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+T Cells”;Cancer Research; (2004); 64:1140-1145.
Tomlinson et al. “The Repertoire of Human Germline VHSequences Reveals about Fifty Groups of VHSegments with Different Hypervariable Loops”;J. Mol. Biol.; (1992); 227:776-798.
Cox et al. “A directory of human germ-line Vκsegments reveals a strong bias in their usage”;Eur. J. Immunol.; (1994); 24:827-836.
Chen Haibin
Huang Haichun
Korman Alan J.
Passmore David B.
Selby Mark J.
Baker & Botts L.L.P.
Medarex Inc.
Ouspenski Ilia
LandOfFree
Human monoclonal antibodies to programmed death ligand 1... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human monoclonal antibodies to programmed death ligand 1..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human monoclonal antibodies to programmed death ligand 1... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2645563